Palmer, Christine D. http://orcid.org/0000-0003-3213-0398
Scallan, Ciaran D.
Kraemer Tardif, Lauren D.
Kachura, Melissa A. http://orcid.org/0000-0001-5910-4443
Rappaport, Amy R.
Koralek, Daniel O.
Uriel, Alison
Gitlin, Leonid
Klein, Joshua
Davis, Matthew J.
Venkatraman, Harshni
Hart, Meghan G.
Jaroslavsky, Jason R. http://orcid.org/0000-0002-9799-2397
Kounlavouth, Sonia
Marrali, Martina http://orcid.org/0000-0001-5248-1430
Nganje, Charmaine N.
Bae, Kyounghwa
Yan, Tiffany
Leodones, Katharyn
Egorova, Milana http://orcid.org/0000-0002-9917-091X
Hong, Sue-Jean
Kuan, Jenchun
Grappi, Silvia
Garbes, Pedro http://orcid.org/0000-0003-0830-3463
Jooss, Karin http://orcid.org/0000-0001-7670-4993
Ustianowski, Andrew
Article History
Received: 27 January 2023
Accepted: 22 May 2023
First Online: 6 June 2023
Competing interests
: This study was sponsored by Gritstone bio, Inc. C.D.P., C.D.S., D.O.K., L.D.K.T., A.R.R., M.A.K., L.G., J.K., M.J.D., H.V., M.G.H., J.R.J., S.K., M.M., C.N.N., K.B., T.Y., K.L., M.E., S.-J.H., J.C.K., P.G., and K.J. are stockholders and either current or previous employees at Gritstone bio, Inc. and may be listed as co-inventors on various pending patent applications related to the vaccine platform presented in this study. D.O.K. is currently an employee and shareholder of Gilead sciences. P.G. holds shares in AstraZeneca and Takeda. The remaining authors declare no competing interests. Participants did not receive compensation for participating in this study.